RS

Ritesh Singh

Active Director Director DIN 08204574
DIN 08204574 First appointment Aug 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Ritesh Singh

Data last updated:

Ritesh Singh is a Director at Innocuous Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Innocuous Pharmaceuticals Private Limited reported revenue of ₹17.3 Lakh (FY 2022).

DIN 08204574
Primary Designation Director
Industry Chemicals
First Appointment 17 Aug 2018
Oldest Company Age 10 yrs
Largest company Innocuous Pharmaceuticals Private Limited · ₹17.3 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20182016₹17.3 Lakh (FY 2022)Active

Board colleagues of Ritesh Singh

NameDINCompanyDesignation
Shail Singh07588782Innocuous Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Innocuous Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ritesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Singh

Ritesh Singh currently holds 1 directorship: Innocuous Pharmaceuticals Private Limited (Director, since 17 Aug 2018, revenue ₹17.3 Lakh (FY 2022)).

Ritesh Singh was first appointed on 17 Aug 2018 as Director at Innocuous Pharmaceuticals Private Limited.

The current boards of Ritesh Singh's companies include Shail Singh (Innocuous Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available